01.02.24 -- Clinical Trial Supply Market Outlook: Key Technology Developments

In this use case, follow along the clinical supplies management journey to learn how GxP inventory replaces fragmented spreadsheet-based processes to optimize visibility, traceability, and compliance.

An inside look at a clinical-stage company focused on bringing its gene therapy from the lab into a clinical setting for patients and families devastated by rare neurological genetic diseases. 

Embarking on a new cardiovascular Phase-2 clinical study, Reata was challenged with finding a randomization and trial supply management (RTSM) solution that would accommodate the study’s highly adaptive trial design and detailed protocol. Uncover the solution in this case study.

As clinical trials grow in complexity, discover how adopting adaptive, unified RTSM technology can help to reduce costs and maintain accurate real-time study data.

Explore critical logistical requirements in autologous cell therapies logistics and learn how to overcome challenges and achieve successful and timely autologous cell therapy trials.

When a new therapeutic drug, medical device, vaccine, or other investigational medicinal product (IMP) is developed, learn why a label must be on its packaging that provides relevant and important information.

Achieving supply chain resilience is crucial, and flexible distribution strategies and ready-to-use depot and logistics networks are instrumental in establishing limitless flexibility and expertise capable of identifying possible risks.

Learn more about the design and performance of passive shippers and how different material and coolant configurations can impact the cost and efficacy of your shipping solution.